 | Up a level |
Damas, José; Munting, Aline; Fellay, Jacques; Haerry, David; Marzolini, Catia; Tarr, Philip E; Steffen, Ana; Braun, Dominique L; Stoeckle, Marcel; Bernasconi, Enos; Tshikung, Olivier Nawej; Fux, Christoph A; Darling, Katharine E A; Béguelin, Charles; Wandeler, Gilles; Cavassini, Matthias; Surial, Bernard (2024). Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV. (In Press). Clinical infectious diseases Oxford University Press 10.1093/cid/ciae189
Glass, Tracy R; Günthard, Huldrych; Calmy, Alexandra; Bernasconi, Enos; Scherrer, Alexandra U; Battegay, Manuel; Steffen, Ana; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cavassini, Matthias; Furrer, Hansjakob (2021). The role of HIV asymptomatic status when starting ART on adherence and treatment outcomes and implications for test and treat: the Swiss HIV Cohort Study. Clinical infectious diseases, 72(8), pp. 1413-1421. Oxford University Press 10.1093/cid/ciaa239
Dietrich, Léna G; Barceló, Catalina; Thorball, Christian W; Ryom, Lene; Burkhalter, Felix; Hasse, Barbara; Furrer, Hansjakob; Weisser, Maja; Steffen, Ana; Bernasconi, Enos; Cavassini, Matthias; de Seigneux, Sophie; Csajka, Chantal; Fellay, Jacques; Ledergerber, Bruno; Tarr, Philip E (2020). Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate. Clinical infectious diseases, 70(5), pp. 890-897. Oxford University Press 10.1093/cid/ciz280
